BGMS insider sells 135,793 shares at $6

Bio Green Med Solution (BGMS): A reporting person filed a Form 4 showing an open‑market sale of common stock.

Accepted by SEC EDGAR 10/16/2025 - 12:00 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Bio Green Med Solution (BGMS): A reporting person filed a Form 4 showing an open‑market sale of common stock. On 10/14/2025, the filer sold 135,793 shares at $6 per share (Transaction Code S). Following the transaction, the filer reported 268,672 shares beneficially owned with direct ownership.

Insights

Equity Ownership and Insider Transactions Analyst

Insider sold 135,793 shares at $6; remains a large holder with 268,672 shares.

The filing reports a sale of 135,793 shares of Bio Green Med Solution, Inc. (BGMS) common stock on 10/14/2025, coded "S" (sale). The sale price was $6 per share. Following this transaction, the reporting person beneficially owns 268,672 shares, held directly.

The filer is identified as a 10% Owner. This indicates a significant holder reduced their position but maintained a substantial stake. The disclosure does not provide the company’s total shares outstanding, so the change in ownership percentage cannot be determined from this filing alone. The form shows no derivative activity.

Key items to watch include any subsequent Form 4 filings that show additional sales or purchases and any future disclosures that clarify whether transactions occur under a plan. The signature date is 10/16/2025. Near term, monitor for further changes in beneficial ownership and any related governance or reporting updates.

Insider Trade Summary

Net Seller: 135,793 shares

Net Sell 1 txn

Insider Ong Yee Lung

Role 10% Owner

Sold 135,793 shs ($815K)

Type	Security	Shares	Price	Value
Sale	Common Stock	135,793	$6.00	$815K

Holdings After Transaction: Common Stock — 268,672 shares (Direct)

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ong Yee Lung

(Last) (First) (Middle)

9 JALAN LAWA 3 TAMAN PELANGI

INDAH ULU TIRAM

(Street)

JOHOR BAHRU N8 81100

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bio Green Med Solution, Inc. [ BGMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/14/2025		S		135,793	D	$6	268,672	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Ong Yee Lung	10/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.